Author:
Meirson Tomer,Goldstein Daniel A,Gyawali Bishal,Tannock Ian F
Reference26 articles.
1. Evaluating trials of adjuvant therapy: is there benefit for people with resected renal cancer?;Tannock;J Clin Oncol,2023
2. Abemaciclib combined with endocrine therapy for the adjuvant treatment of HR+, HER2-, node-positive, high-risk, early breast cancer (monarchE);Johnston;J Clin Oncol,2020
3. Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial;Johnston;Lancet Oncol,2023
4. Cautionary tails;Del Paggio;Ann Oncol,2021
5. Observer bias in randomized clinical trials with time-to-event outcomes: systematic review of trials with both blinded and non-blinded outcome assessors;Hróbjartsson;Int J Epidemiol,2014
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献